Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sonoma Pharmaceuticals, Inc. (SNOA)
USD1.23
+0.00 (-1.63%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
645 Molly Lane 30189
Woodstock, GA, US
Woodstock, GA, US
CEO
Amy Trombly
Website
sonomapharma.com
IPO
2007-01-25
CIK 1367083 ISIN US83558L3033
Description
Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international territories. Its comprehensive product line features: Epicyn: an antimicrobial cleanser for facial use. Levicyn: a prescription HOCl-based treatment formulated to ease the burning, itching, and pain associated with numerous dermatological issues. Celacyn gel: a topical HOCl-based prescription product engineered to facilitate efficient healing and management of both new and old scars. SebuDerm: designed to soothe the burning, itching, redness, scaling, and discomfort linked to seborrhea and seborrheic dermatitis. Acuicyn: an HOCl-based solution for alleviating ocular itch and inflammation, while also maintaining cleanliness around the eyes. Microcyn: a topical HOCl product family aimed at accelerating wound healing by combating a wide spectrum of pathogens, including antibiotic-resistant strains that can impede natural recovery. MicrocynAH: an HOCl-based solution specifically for animals, providing relief for common conditions like hot spots, scratches, skin rashes, post-surgical sites, and irritated skin to support healing. Microdacyn60: an oral care solution for treating infections of the mouth and throat. MucoClyns: suitable for emergency use and safe for application on mucous membranes, cuts, abrasions, burns, and other body surfaces. Endocyn: a series of solutions for root canal irrigation. Pediacyn: a hydrogel designed for atopic dermatitis. Ocucyn: a cleanser for eyelids and eyelashes. Gramaderm: for the topical treatment of mild to moderate acne. Nanocyn: a hospital-grade disinfectant. Sinudox: for nasal irrigation purposes. Originally incorporated in 1999 as Oculus Innovative Sciences, Inc., the company officially rebranded to Sonoma Pharmaceuticals, Inc. in December 2016. Its headquarters are located in Woodstock, Georgia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.23
+0.00 (-1.63%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
231.3K
Beta
1.30
Float Shares
1.72M
Free Float %
99.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +5.50% | +7.48% | -52.67% | -67.79% | -68.41% | -62.17% | -95.17% | -99.25% | -99.86% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
1.23
Ratings Trend (MoM)
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-18.80
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+36.7% ★ Q1'26: +48.1% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+32.3% ★ Q1'26: +47.6% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-16.6% Q1'26: -0.8% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-12.6% Q1'26: -6.3% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-160.0% Q1'26: -91.3% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+35.7% Q1'26: +42.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-0.34× Q1'26: -0.66× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.85M
est: 13.05M (+6.2%)
|
9.37M
est: 15.05M (-37.8%)
|
12.83M
est: 14.57M (-12.0%)
|
16.66M
est: 17.40M (-4.3%)
|
18.97M
est: 19.00M (-0.2%)
|
17.93M
est: 19.20M (-6.6%)
|
18.63M
est: 29.86M (-37.6%)
|
12.63M
est: 37.14M (-66.0%)
|
13.27M
est: 13.56M (-2.1%)
|
12.74M
est: 12.70M (+0.3%)
|
14.29M
est: 15.47M (-7.6%)
|
20.66M
20.66M – 20.66M
+33.5% YoY
|
23.91M
23.91M – 23.91M
+15.8% YoY
|
26.95M
26.95M – 26.95M
+12.7% YoY
|
| EBITDA |
-7.95M
est: -4.08M (-94.6%)
|
-14.48M
est: -4.71M (-207.3%)
|
-12.69M
est: -4.56M (-178.3%)
|
-13.75M
est: -5.45M (-152.5%)
|
-10.85M
est: -5.95M (-82.6%)
|
-3.22M
est: -6.01M (+46.5%)
|
-3.22M
est: -9.34M (+65.5%)
|
-5.22M
est: -11.62M (+55.1%)
|
-5.06M
est: -4.24M (-19.3%)
|
-4.86M
est: -3.80M (-27.8%)
|
-2.77M
est: -4.63M (+40.2%)
|
-6.18M
-6.18M – -6.18M
-33.5% YoY
|
-7.15M
-7.15M – -7.15M
-15.8% YoY
|
-8.06M
-8.06M – -8.06M
-12.7% YoY
|
| EBIT |
-8.20M
est: -4.24M (-93.4%)
|
-14.72M
est: -4.89M (-201.0%)
|
-12.93M
est: -4.73M (-173.3%)
|
-14.24M
est: -5.65M (-151.8%)
|
-11.31M
est: -6.17M (-83.2%)
|
-3.53M
est: -6.24M (+43.4%)
|
-3.45M
est: -9.70M (+64.4%)
|
-5.41M
est: -12.07M (+55.2%)
|
-5.18M
est: -4.40M (-17.7%)
|
-5.03M
est: -3.92M (-28.3%)
|
-2.91M
est: -4.77M (+39.1%)
|
-6.38M
-6.38M – -6.38M
-33.5% YoY
|
-7.38M
-7.38M – -7.38M
-15.8% YoY
|
-8.32M
-8.32M – -8.32M
-12.7% YoY
|
| Net Income |
-8.20M
est: -1.18B (+99.3%)
|
-10.16M
est: -681.31M (+98.5%)
|
9.27M
est: 466.86M (-98.0%)
|
-14.33M
est: -639.98M (+97.8%)
|
-11.80M
est: -316.95M (+96.3%)
|
-3.31M
est: -94.81M (+96.5%)
|
-3.95M
est: -212.21M (+98.1%)
|
-5.09M
est: -75.95M (+93.3%)
|
-5.15M
est: -30.78M (+83.3%)
|
-4.84M
est: -12.68M (+61.9%)
|
-3.46M
est: -1.13M (-206.4%)
|
-2.71M
-2.71M – -2.71M
-140.3% YoY
|
-943.0K
-943.0K – -943.0K
+65.2% YoY
|
117.9K
117.9K – 117.9K
+112.5% YoY
|
| SGA |
12.41M
est: 7.98M (+55.7%)
|
15.56M
est: 9.20M (+69.1%)
|
17.07M
est: 8.90M (+91.7%)
|
19.92M
est: 10.64M (+87.3%)
|
18.62M
est: 11.61M (+60.3%)
|
14.17M
est: 11.74M (+20.8%)
|
9.45M
est: 18.25M (-48.2%)
|
9.76M
est: 22.70M (-57.0%)
|
8.84M
est: 8.29M (+6.7%)
|
7.58M
est: 7.46M (+1.5%)
|
7.36M
est: 9.09M (-19.0%)
|
12.14M
12.14M – 12.14M
+33.5% YoY
|
14.05M
14.05M – 14.05M
+15.8% YoY
|
15.84M
15.84M – 15.84M
+12.7% YoY
|
| EPS |
-130.37
est: -949.50 (+86.3%)
|
-117.86
est: -549.00 (+78.5%)
|
-221.70
est: 376.20 (-158.9%)
|
-284.66
est: -515.70 (+44.8%)
|
-127.68
est: -255.40 (+50.0%)
|
-22.40
est: -76.40 (+70.7%)
|
-23.65
est: -171.00 (+86.2%)
|
-19.17
est: -61.20 (+68.7%)
|
-15.18
est: -24.80 (+38.8%)
|
-5.32
est: -7.53 (+29.3%)
|
-2.79
est: -0.67 (-316.4%)
|
-1.61
-1.61 – -1.61
-140.3% YoY
|
-0.56
-0.56 – -0.56
+65.2% YoY
|
0.07
0.07 – 0.07
+112.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-10 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-09 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-03 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-02 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-06-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.31M
OE per share TTM
-1.27
Owner's Yield
-113.66%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
5.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
17
Total invested
143.7K
Insider transactions (90d)
1
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (“Oculus”, the “Reporting Person”) | 2.00M | 43.01% | 2.00M | — | 2.00M | — | CO | Delaware | 2014-04-10 | ↗ |
| 2 | Barry Honig | 1.98M | 5.29% | 1.98M | — | 1.98M | — | IN | United States | 2013-02-15 | ↗ |
| 3 | BAM Capital, LLC | 1.10M | 5.87% | — | 1.10M | — | — | OO | Delaware, U.S.A. | 2009-05-15 | ↗ |
| 4 | BAM Management, LLC | 1.10M | 5.87% | — | 1.10M | — | — | OO | Delaware, U.S.A. | 2009-05-15 | ↗ |
| 5 | BAM Opportunity Fund, L.P. | 1.10M | 5.87% | — | 1.10M | — | — | PN | Delaware, U.S.A. | 2009-05-15 | ↗ |
| 6 | Hal Mintz | 1.10M | 5.87% | — | 1.10M | — | — | IN | United States of America | 2009-05-15 | ↗ |
| 7 | Ross Berman | 1.10M | 5.87% | — | 1.10M | — | — | IN | United States of America | 2009-05-15 | ↗ |
| 8 | 13G | 831.3K | 5.40% | — | 831.3K | — | 831.3K | HC, OO | United States Citizen | 2015-01-30 | ↗ |
| 9 | Daniel K. Turner, III | 571.4K | 9.26% | — | 571.4K | — | — | IN | Delaware | 2018-03-09 | ↗ |
| 10 | Montreux Equity Management V, LLC | 571.4K | 9.26% | — | 571.4K | — | — | CO | Delaware | 2018-03-09 | ↗ |
| 11 | Montreux Equity Partners V, L.P. | 571.4K | 9.26% | — | 571.4K | — | — | PN | Delaware | 2018-03-09 | ↗ |
| 12 | 36-3452497 | 256.9K | 3.90% | 20.0K | — | 256.9K | — | IA | Illinois | 2019-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
17
+2 vs prev Q
New positions
5
Closed positions
3
Increased
9
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | DRW SECURITIES, LLC | 61.0K +43.9K (+257.2%) | 222.0K +155.7K (+235.1%) | 3.56% +2.519 pp | 0.01% +0.005 pp | USD3.71 -1.9% | 2 qtrs — |
| 2 | VANGUARD GROUP INC | 18.9K -2.0K (-9.5%) | 68.7K -12.2K (-15.1%) | 1.10% -0.169 pp | 0.00% +0.000 pp | USD3.88 -6.2% | 2 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 15.9K -1.7K (-9.7%) | 57.9K -10.4K (-15.3%) | 0.93% -0.145 pp | 0.00% +0.000 pp | USD2.22 +64.0% | 4 qtrs — |
| 4 | MCKINLEY CARTER WEALTH SERVICES, INC. | 11.2K +11.2K (+100.0%) | 40.7K +40.7K (+100.0%) | 0.68% +0.680 pp | 0.00% +0.002 pp | USD3.64 +0.0% | 1 qtrs NEW |
| 5 | GLOBAL RETIREMENT PARTNERS, LLC | 772.00 +334.0 (+76.3%) | 2.8K +1.1K (+65.4%) | 0.05% +0.018 pp | 0.00% +0.000 pp | USD3.77 -3.4% | 2 qtrs — |
| 6 | ADVISOR GROUP HOLDINGS, INC. | 500.00 +500.0 (+100.0%) | 1.8K +1.8K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.000 pp | USD3.64 +0.0% | 1 qtrs NEW |
| 7 | TOWER RESEARCH CAPITAL LLC (TRC) | 385.00 -1.2K (-74.9%) | 1.4K -4.6K (-76.5%) | 0.02% -0.071 pp | 0.00% 0.000 pp | USD3.35 +8.7% | 6 qtrs — |
| 8 | JPMORGAN CHASE & CO | 121.00 -2.0 (-1.6%) | 440.00 -37.0 (-7.8%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.07 +18.6% | 6 qtrs — |
| 9 | BLACKROCK, INC. | 113.00 +— (+0.0%) | 411.00 -27.0 (-6.2%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.06 +19.0% | 6 qtrs — |
| 10 | US BANCORP \DE\ | 25.00 +— (+0.0%) | 91.00 -6.0 (-6.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.04 +19.7% | 6 qtrs — |
| 11 | BANK OF AMERICA CORP /DE/ | 18.00 +1.0 (+5.9%) | 65.00 -1.0 (-1.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.61 +39.5% | 6 qtrs — |
| 12 | UBS GROUP AG | 6.00 -102.0 (-94.4%) | 22.00 -397.0 (-94.7%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD2.83 +28.6% | 6 qtrs — |
| 13 | MORGAN STANLEY | 4.00 +— (+0.0%) | 15.00 -1.0 (-6.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 +21.3% | 6 qtrs — |
| 14 | QUAKER WEALTH MANAGEMENT, LLC | 3.00 +— (+0.0%) | 11.00 -1.0 (-8.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.67 +36.3% | 3 qtrs — |
| 15 | DANSKE BANK A/S | 1.00 +— (+0.0%) | 4.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 +21.3% | 6 qtrs — |
| 16 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | — -646.0 (-100.0%) | — -2.5K (-100.0%) | 0.00% -0.039 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 17 | SBI SECURITIES CO., LTD. | — -1.0 (-100.0%) | — -4.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 18 | MAI CAPITAL MANAGEMENT | — -124.0 (-100.0%) | — -482.0 (-100.0%) | 0.00% -0.008 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 19 | CITIGROUP INC | — -656.0 (-100.0%) | — -2.5K (-100.0%) | 0.00% -0.040 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 20 | FMR LLC | — -2.0 (-100.0%) | — -7.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 21 | ALLWORTH FINANCIAL LP | — -3.0 (-100.0%) | — -12.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 20.9K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
50.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+50,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027-01-28 | Jacoby Vanessa | Director | — | — | Stock option (right to buy) | 10,000 | 10,000.00 | 100.00M | 0 | D | ↗ |
| 2026-01-02 | Weigerstorfer Philippe | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.68 | 36.8K | 20,001 | D | ↗ |
| 2026-01-02 | Trombly Amy Moss | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 42,185 | D | ↗ |
| 2026-01-02 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.68 | 36.8K | 20,001 | D | ↗ |
| 2026-01-02 | Dal Poggetto John | Officer | A-Award | A | Restricted Stock Units | 5,000 | 0.00 | — | 25,250 | D | ↗ |
| 2026-01-02 | DVONCH JEROME J | Officer | A-Award | A | Restricted Stock Units | 5,000 | 0.00 | — | 34,391 | D | ↗ |
| 2026-01-02 | Birnbaum Jay E | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.68 | 36.8K | 20,001 | D | ↗ |
| 2025-06-19 | Trombly Amy Moss | Officer | A-Award | A | Restricted Stock Units | 13,500 | 0.00 | — | 32,185 | D | ↗ |
| 2025-06-19 | Thornton Bruce | Officer | A-Award | A | Restricted Stock Units | 13,500 | 0.00 | — | 32,191 | D | ↗ |
| 2025-06-19 | Dal Poggetto John | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 20,250 | D | ↗ |
| 2025-06-19 | DVONCH JEROME J | Officer | A-Award | A | Restricted Stock Units | 13,500 | 0.00 | — | 25,515 | D | ↗ |
| 2025-01-02 | Weigerstorfer Philippe | Director | A-Award | A | Stock option (right to buy) | 7,500 | 2.68 | 20.1K | 10,001 | D | ↗ |
| 2025-01-02 | Trombly Amy Moss | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 18,685 | D | ↗ |
| 2025-01-02 | Thornton Bruce | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 18,691 | D | ↗ |
| 2025-01-02 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock option (right to buy) | 7,500 | 2.68 | 20.1K | 10,044 | D | ↗ |
| 2025-01-02 | Dal Poggetto John | Officer | A-Award | A | Restricted Stock Units | 7,500 | 0.00 | — | 10,250 | D | ↗ |
| 2025-01-02 | DVONCH JEROME J | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 15,891 | D | ↗ |
| 2025-01-02 | Birnbaum Jay E | Director | A-Award | A | Stock option (right to buy) | 7,500 | 2.68 | 20.1K | 10,029 | D | ↗ |
| 2024-06-20 | Trombly Amy Moss | Officer | A-Award | A | Common Stock, $0.0001 par value | 53,586 | 0.00 | — | 153,586 | — | ↗ |
| 2024-06-20 | Thornton Bruce | Officer | A-Award | A | Common Stock, $0.0001 par value | 53,586 | 0.00 | — | 154,411 | — | ↗ |
| 2024-06-20 | Dal Poggetto John | Officer | A-Award | A | Common Stock, $0.0001 par value | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2024-06-20 | DVONCH JEROME J | Officer | A-Award | A | Common Stock, $0.0001 par value | 53,586 | 0.00 | — | 84,595 | — | ↗ |
| 2023-12-29 | Trombly Amy Moss | Officer | A-Award | A | Stock option (right to buy) | 60,000 | 0.18 | 10.8K | 173,648 | — | ↗ |
| 2023-12-29 | Thornton Bruce | Officer | A-Award | A | Stock option (right to buy) | 60,000 | 0.18 | 10.8K | 176,781 | — | ↗ |
| 2023-12-29 | Dal Poggetto John | Officer | A-Award | A | Stock option (right to buy) | 50,000 | 0.18 | 9.0K | 55,000 | — | ↗ |
| 2023-12-29 | DVONCH JEROME J | Officer | A-Award | A | Stock option (right to buy) | 60,000 | 0.18 | 10.8K | 117,777 | — | ↗ |
| 2023-07-17 | Dal Poggetto John | Officer | — | D | Stock option (right to buy) | 5,000 | 1.15 | 5.8K | 0 | — | ↗ |
| 2023-06-30 | Trombly Amy Moss | Officer | A-Award | A | Common Stock, $0.0001 par value | 100,000 | 0.00 | — | 213,648 | — | ↗ |
| 2023-06-30 | Thornton Bruce | Officer | A-Award | A | Common Stock, $0.0001 par value | 100,000 | 0.00 | — | 216,781 | — | ↗ |
| 2023-04-07 | DVONCH JEROME J | Officer | — | D | Common Stock | 0 | 0.00 | — | 31,009 | — | ↗ |
| 2022-12-29 | White Chad Norman | Officer | A-Award | A | Stock option (right to buy) | 9,753 | 1.08 | 10.5K | 14,753 | — | ↗ |
| 2022-12-29 | Weigerstorfer Philippe | Director | A-Award | A | Stock option (right to buy) | 20,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-12-29 | Trombly Amy Moss | Officer | A-Award | A | Stock option (right to buy) | 40,000 | 0.00 | — | 113,648 | — | ↗ |
| 2022-12-29 | Thornton Bruce | Officer | A-Award | A | Stock option (right to buy) | 40,000 | 1.08 | 43.2K | 116,781 | — | ↗ |
| 2022-12-29 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock option (right to buy) | 20,000 | 1.08 | 21.6K | 53,252 | — | ↗ |
| 2022-12-29 | Birnbaum Jay E | Director | A-Award | A | Stock option (right to buy) | 20,000 | 1.08 | 21.6K | 52,904 | — | ↗ |
| 2022-10-03 | White Chad Norman | Officer | — | D | Stock Option (right to buy) | 5,000 | 2.21 | 11.1K | 0 | — | ↗ |
| 2022-01-14 | Weigerstorfer Philippe | Director | A-Award | A | Stock option (right to buy) | 30,000 | 4.60 | 138.0K | 30,000 | — | ↗ |
| 2022-01-14 | Trombly Amy Moss | Officer | A-Award | A | Stock option (right to buy) | 30,000 | 4.60 | 138.0K | 73,648 | — | ↗ |
| 2022-01-14 | Thornton Bruce | Officer | A-Award | A | Stock option (right to buy) | 30,000 | 4.60 | 138.0K | 76,781 | — | ↗ |
| 2022-01-14 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock option (right to buy) | 30,000 | 4.60 | 138.0K | 33,252 | — | ↗ |
| 2022-01-14 | DVONCH JEROME J | Officer | A-Award | A | Stock option (right to buy) | 30,000 | 4.60 | 138.0K | 57,777 | — | ↗ |
| 2022-01-14 | Birnbaum Jay E | Director | A-Award | A | Stock option (right to buy) | 30,000 | 4.60 | 138.0K | 32,904 | — | ↗ |
| 2021-01-07 | Trombly Amy Moss | Officer | A-Award | A | Stock option (right to buy) | 27,777 | 8.03 | 223.0K | 43,648 | — | ↗ |
| 2021-01-07 | Thornton Bruce | Officer | A-Award | A | Stock option (right to buy) | 27,777 | 8.03 | 223.0K | 47,377 | — | ↗ |
| 2021-01-07 | DVONCH JEROME J | Officer | A-Award | A | Stock option (right to buy) | 27,777 | 8.03 | 223.0K | 27,777 | — | ↗ |
| 2020-09-08 | DVONCH JEROME J | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-23 | Edwards Robert Grant | Officer | A-Award | A | Common Stock, $0.0001 par value | 2,609 | 0.00 | — | 2,609 | — | ↗ |
| 2020-04-23 | Dal Poggetto John | Officer | A-Award | A | Common Stock, $0.0001 par value | 3,086 | 0.00 | — | 3,201 | — | ↗ |
| 2020-04-14 | Edwards Robert Grant | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-02 | Trombly Amy Moss | Officer | A-Award | A | Stock option (right to buy) | 2,380 | 4.55 | 10.8K | 15,871 | — | ↗ |
| 2019-12-31 | Trombly Amy Moss | Officer | A-Award | A | Stock option (right to buy) | 13,491 | 4.36 | 58.8K | 13,491 | — | ↗ |
| 2019-12-31 | Dal Poggetto John | Officer | A-Award | A | Stock option (right to buy) | 13,000 | 4.36 | 56.7K | 18,496 | — | ↗ |
| 2019-09-27 | Trombly Amy Moss | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-09-27 | Dal Poggetto John | Officer | — | D | Stock Option (right to buy) | 420 | 52.20 | 21.9K | 0 | — | ↗ |
| 2019-01-14 | Schutz James J | Director | H-ExpireLong | D | Stock option (right to buy) | 3,928 | 70.35 | 276.3K | 178,803 | — | ↗ |
| 2019-01-14 | Miller Robert E | Other | H-ExpireLong | D | Stock option (right to buy) | 1,785 | 43.75 | 78.1K | 191,301 | — | ↗ |
| 2019-01-10 | Sandford Frederick J | Director / Officer | A-Award | A | Stock option (right to buy) | 50,000 | 0.72 | 35.9K | 450,000 | — | ↗ |
| 2018-12-11 | Sandford Frederick J | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-09-19 | Weigerstorfer Philippe | Director | — | D | Common Stock | 0 | 0.00 | — | 22,500 | — | ↗ |
| 2018-07-20 | Schutz James J | Director / Officer | A-Award | A | Stock option (right to buy) | 67,733 | 2.41 | 163.2K | 193,358 | — | ↗ |
| 2018-07-20 | Miller Robert E | Officer | A-Award | A | Stock option (right to buy) | 67,733 | 2.41 | 163.2K | 209,071 | — | ↗ |
| 2018-05-30 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,781 | 0.00 | — | 48,728 | — | ↗ |
| 2018-05-30 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,538 | 0.00 | — | 46,520 | — | ↗ |
| 2018-05-30 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,052 | 0.00 | — | 51,659 | — | ↗ |
| 2018-03-13 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 1,200 | 4.10 | 4.9K | 18,868 | — | ↗ |
| 2018-03-12 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 1,200 | 4.03 | 4.8K | 17,668 | — | ↗ |
| 2018-03-09 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par vlue per share | 1,200 | 3.90 | 4.7K | 15,268 | — | ↗ |
| 2018-03-08 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 2,473 | 3.99 | 9.9K | 35,858 | — | ↗ |
| 2018-03-01 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,958 | 0.00 | — | 46,947 | — | ↗ |
| 2018-03-01 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,691 | 0.00 | — | 44,982 | — | ↗ |
| 2018-03-01 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,157 | 0.00 | — | 50,607 | — | ↗ |
| 2018-03-01 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,424 | 0.00 | — | 43,417 | — | ↗ |
| 2018-01-02 | Schutz James J | Director / Officer | A-Award | A | Common Stock, $0.0001 par value per share | 17,211 | 0.00 | — | 33,385 | — | ↗ |
| 2018-01-02 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 17,211 | 0.00 | — | 44,989 | — | ↗ |
| 2018-01-02 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 17,211 | 0.00 | — | 43,291 | — | ↗ |
| 2018-01-02 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 25,817 | 0.00 | — | 49,450 | — | ↗ |
| 2018-01-02 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 17,211 | 0.00 | — | 41,993 | — | ↗ |
| 2017-11-30 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 345 | 4.95 | 1.7K | 16,174 | — | ↗ |
| 2017-11-29 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 400 | 5.03 | 2.0K | 15,829 | — | ↗ |
| 2017-11-29 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 500 | 5.03 | 2.5K | 12,778 | — | ↗ |
| 2017-11-29 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 14,317 | 0.00 | — | 27,778 | — | ↗ |
| 2017-11-29 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 14,130 | 0.00 | — | 26,080 | — | ↗ |
| 2017-11-29 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 13,757 | 0.00 | — | 23,633 | — | ↗ |
| 2017-11-29 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 13,944 | 0.00 | — | 24,782 | — | ↗ |
| 2017-11-24 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 254 | 5.05 | 1.3K | 15,429 | — | ↗ |
| 2017-11-21 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 500 | 5.04 | 2.5K | 12,278 | — | ↗ |
| 2017-08-29 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,210 | 0.00 | — | 13,471 | — | ↗ |
| 2017-08-29 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,045 | 0.00 | — | 11,950 | — | ↗ |
| 2017-08-29 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 715 | 0.00 | — | 9,876 | — | ↗ |
| 2017-08-29 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 880 | 0.00 | — | 10,838 | — | ↗ |
| 2017-08-10 | Umscheid Marc | Officer | P-Purchase | A | Common Stock, $0.0001 par value | 600 | 5.31 | 3.2K | 3,392 | — | ↗ |
| 2017-08-10 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock, $0.0001 par value | 929 | 5.46 | 5.1K | 15,175 | — | ↗ |
| 2017-08-10 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value | 2,264 | 5.30 | 12.0K | 10,728 | — | ↗ |
| 2017-06-29 | Umscheid Marc | Officer | A-Award | A | Restricted Shares Common Stock, $0.0001 par value per share | 2,042 | 6.94 | 14.2K | 2,792 | — | ↗ |
| 2017-06-29 | Schutz James J | Director / Officer | A-Award | A | Restricted Shares Common Stock, $0.0001 par value per share | 2,406 | 6.94 | 16.7K | 14,246 | — | ↗ |
| 2017-06-29 | Northey Robert Allen | Officer | A-Award | A | Restricted Shares Common Stock, $0.0001 par value per share | 3,404 | 6.94 | 23.6K | 8,082 | — | ↗ |
| 2017-06-29 | Miller Robert E | Officer | A-Award | A | Restricted Shares Common Stock, $0.0001 par value per share | 4,124 | 6.94 | 28.6K | 20,088 | — | ↗ |
| 2017-05-30 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,036 | 0.00 | — | 12,261 | — | ↗ |
| 2017-05-30 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 895 | 0.00 | — | 10,905 | — | ↗ |
| 2017-05-30 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 612 | 0.00 | — | 9,161 | — | ↗ |
| 2017-05-30 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 754 | 0.00 | — | 9,958 | — | ↗ |
| 2017-04-03 | Umscheid Marc | Officer | A-Award | A | Stock option (right to buy) | 17,000 | 7.06 | 120.0K | 72,000 | — | ↗ |
| 2017-04-03 | Schutz James J | Director / Officer | A-Award | A | Stock option (right to buy) | 30,000 | 7.06 | 211.8K | 133,658 | — | ↗ |
| 2017-04-03 | Northey Robert Allen | Officer | A-Award | A | Stock option (right to buy) | 17,000 | 7.06 | 120.0K | 60,310 | — | ↗ |
| 2017-04-03 | Miller Robert E | Officer | A-Award | A | Stock option (right to buy) | 30,000 | 7.06 | 211.8K | 140,866 | — | ↗ |
| 2017-03-09 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 250 | 7.14 | 1.8K | 8,464 | — | ↗ |
| 2017-03-08 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 750 | 6.97 | 5.2K | 7,714 | — | ↗ |
| 2017-03-06 | Umscheid Marc | Officer | P-Purchase | A | Common Stock, par value $0.0001 per share | 750 | 6.82 | 5.1K | 750 | — | ↗ |
| 2017-03-04 | Dal Poggetto John | Officer | — | D | Stock Option (right to buy) | 1,648 | 175.50 | 289.2K | 0 | — | ↗ |
| 2017-03-03 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share | 104 | 6.75 | 702.00 | 11,840 | — | ↗ |
| 2017-03-01 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 976 | 0.00 | — | 11,225 | — | ↗ |
| 2017-03-01 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 843 | 0.00 | — | 10,010 | — | ↗ |
| 2017-03-01 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 577 | 0.00 | — | 8,549 | — | ↗ |
| 2017-03-01 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 710 | 0.00 | — | 9,204 | — | ↗ |
| 2017-02-28 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 2,250 | 0.00 | — | 10,249 | — | ↗ |
| 2017-02-28 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 2,250 | 0.00 | — | 9,167 | — | ↗ |
| 2017-02-28 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 2,250 | 0.00 | — | 7,972 | — | ↗ |
| 2017-02-28 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 2,250 | 0.00 | — | 8,494 | — | ↗ |
| 2017-01-19 | Umscheid Marc | Officer | A-Award | A | Stock option (right to buy) | 55,000 | 5.15 | 283.3K | 55,000 | — | ↗ |
| 2016-12-31 | Umscheid Marc | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-12-08 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 4.88 | 4.9K | 11,040 | — | ↗ |
| 2016-12-08 | Miller Robert E | Officer | P-Purchase | A | Common Stock, $0.0001 par value per share | 5,000 | 4.86 | 24.3K | 6,714 | — | ↗ |
| 2016-11-30 | Schutz James J | Director / Officer | A-Award | A | Stock option (right to buy) | 50,000 | 4.81 | 240.5K | 103,658 | — | ↗ |
| 2016-11-30 | Northey Robert Allen | Officer | A-Award | A | Common Stock, $0.0001 par value per share | 4,678 | 4.81 | 22.5K | 4,678 | — | ↗ |
| 2016-11-29 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,423 | 0.00 | — | 7,999 | — | ↗ |
| 2016-11-29 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,229 | 0.00 | — | 6,917 | — | ↗ |
| 2016-11-29 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 841 | 0.00 | — | 5,722 | — | ↗ |
| 2016-11-29 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,035 | 0.00 | — | 6,244 | — | ↗ |
| 2016-09-19 | Dal Poggetto John | Officer | — | D | Stock Option (right to buy) | 238 | 133.65 | 31.8K | 0 | — | ↗ |
| 2016-08-29 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,423 | 0.00 | — | 5,688 | — | ↗ |
| 2016-08-29 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 974 | 0.00 | — | 4,881 | — | ↗ |
| 2016-08-29 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 1,199 | 0.00 | — | 5,209 | — | ↗ |
| 2016-08-15 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock | 1,328 | 3.66 | 4.9K | 6,505 | — | ↗ |
| 2016-05-31 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 6,765 | 0.00 | — | 24,643 | — | ↗ |
| 2016-05-31 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 5,090 | 0.00 | — | 21,327 | — | ↗ |
| 2016-05-31 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 4,188 | 0.00 | — | 19,541 | — | ↗ |
| 2016-05-31 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 4,445 | 0.00 | — | 20,051 | — | ↗ |
| 2016-02-29 | MCLAUGHLIN JOHN | Director | A-Award | A | Common Stock, $0.0001 par value per share | 6,628 | 0.00 | — | 6,628 | — | ↗ |
| 2016-02-29 | Harrison Russell Joseph | Director | A-Award | A | Common Stock, $0.0001 par value per share | 4,987 | 0.00 | — | 4,987 | — | ↗ |
| 2016-02-29 | Birnbaum Jay E | Director | A-Award | A | Common Stock, $0.0001 par value per share | 11,250 | 0.00 | — | 15,353 | — | ↗ |
| 2016-02-29 | BARBARI SHARON SURREY | Director | A-Award | A | Common Stock, $0.0001 par value per share | 4,356 | 0.00 | — | 4,356 | — | ↗ |
| 2016-02-25 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 1.00 | 5.0K | 25,885 | — | ↗ |
| 2015-11-30 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Options (Rights to Buy) | 7,488 | 1.24 | 9.3K | 146,144 | — | ↗ |
| 2015-11-30 | Harrison Russell Joseph | Director | A-Award | A | Stock Options (Rights to Buy) | 5,633 | 1.24 | 7.0K | 89,487 | — | ↗ |
| 2015-11-30 | Birnbaum Jay E | Director | A-Award | A | Stock Options (Rights to Buy) | 4,635 | 1.24 | 5.7K | 174,041 | — | ↗ |
| 2015-08-31 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Options (Rights to Buy) | 7,774 | 1.21 | 9.4K | 138,656 | — | ↗ |
| 2015-08-31 | Harrison Russell Joseph | Director | A-Award | A | Stock Options (Rights to Buy) | 5,849 | 1.21 | 7.1K | 83,854 | — | ↗ |
| 2015-08-31 | Birnbaum Jay E | Director | A-Award | A | Stock Options (Rights to Buy) | 4,813 | 1.21 | 5.8K | 169,406 | — | ↗ |
| 2015-08-31 | BARBARI SHARON SURREY | Director | A-Award | A | Stock Options (Rights to Buy) | 5,109 | 1.21 | 6.2K | 76,048 | — | ↗ |
| 2015-08-24 | Dal Poggetto John | Officer | — | D | Stock Option (right to buy) | 96 | 292.95 | 28.1K | 0 | — | ↗ |
| 2015-06-01 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Options (Rights to Buy) | 10,610 | 0.90 | 9.5K | 130,882 | — | ↗ |
| 2015-06-01 | Harrison Russell Joseph | Director | A-Award | A | Stock Options (Rights to Buy) | 7,983 | 0.90 | 7.2K | 78,005 | — | ↗ |
| 2015-06-01 | Birnbaum Jay E | Director | A-Award | A | Stock Options (Rights to Buy) | 6,568 | 0.90 | 5.9K | 164,593 | — | ↗ |
| 2015-03-02 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Options (right to buy) | 11,026 | 0.86 | 9.5K | 120,272 | — | ↗ |
| 2015-03-02 | Harrison Russell Joseph | Director | A-Award | A | Stock Options (right to buy) | 8,296 | 0.86 | 7.1K | 70,022 | — | ↗ |
| 2015-03-02 | Birnbaum Jay E | Director | A-Award | A | Stock Options (right to buy) | 6,826 | 0.86 | 5.9K | 155,583 | — | ↗ |
| 2015-03-02 | BARBARI SHARON SURREY | Director | A-Award | A | Stock Options (right to buy) | 7,246 | 0.86 | 6.2K | 63,967 | — | ↗ |
| 2014-12-01 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Options (right to buy) | 6,773 | 1.40 | 9.5K | 109,246 | — | ↗ |
| 2014-12-01 | Harrison Russell Joseph | Director | A-Award | A | Stock Options (right to buy) | 5,096 | 1.40 | 7.1K | 61,726 | — | ↗ |
| 2014-12-01 | Birnbaum Jay E | Director | A-Award | A | Stock Options (right to buy) | 4,193 | 1.40 | 5.9K | 148,757 | — | ↗ |
| 2014-12-01 | BARBARI SHARON SURREY | Director | A-Award | A | Stock Options (right to buy) | 4,451 | 1.40 | 6.2K | 56,721 | — | ↗ |
| 2014-10-01 | Birnbaum Jay E | Director | A-Award | A | Stock Options (right to buy) | 15,000 | 2.21 | 33.2K | 144,564 | — | ↗ |
| 2014-07-15 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Options (right to buy) | 3,455 | 2.68 | 9.3K | 87,473 | — | ↗ |
| 2014-07-15 | Harrison Russell Joseph | Director | A-Award | A | Stock Options (right to buy) | 2,599 | 2.68 | 7.0K | 56,630 | — | ↗ |
| 2014-07-15 | Birnbaum Jay E | Director | A-Award | A | Stock Options (right to buy) | 2,139 | 2.68 | 5.7K | 129,564 | — | ↗ |
| 2014-03-26 | BARBARI SHARON SURREY | Director | — | D | Stock Option (Right to Buy) | 50,000 | 4.79 | 239.5K | 0 | — | ↗ |
| 2014-03-04 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Option (Right to Buy) | 55,044 | 3.90 | 214.7K | 84,018 | — | ↗ |
| 2014-03-04 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 50,419 | 3.90 | 196.6K | 127,425 | — | ↗ |
| 2014-02-26 | Harrison Russell Joseph | Director | — | D | Stock Option (Right to Buy) | 7,143 | 3.56 | 25.4K | 0 | — | ↗ |
| 2013-12-18 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Option (Right to Buy) | 6,150 | 3.55 | 21.8K | 28,974 | — | ↗ |
| 2013-12-18 | French Gregory M | Director | A-Award | A | Stock Option (Right to Buy) | 6,150 | 3.55 | 21.8K | 98,357 | — | ↗ |
| 2013-12-18 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 6,150 | 3.55 | 21.8K | 77,006 | — | ↗ |
| 2013-10-01 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Option (Right to Buy) | 2,143 | 2.71 | 5.8K | 22,824 | — | ↗ |
| 2013-10-01 | French Gregory M | Director | A-Award | A | Stock Option (Right to Buy) | 2,143 | 2.71 | 5.8K | 92,207 | — | ↗ |
| 2013-10-01 | Conley Richard K | Director | A-Award | A | Stock Option (Right to Buy) | 2,143 | 2.71 | 5.8K | 80,683 | — | ↗ |
| 2013-10-01 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 2,143 | 2.71 | 5.8K | 70,856 | — | ↗ |
| 2013-09-19 | Schutz James J | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 6.00 | 600.0K | 232,298 | — | ↗ |
| 2013-09-19 | Miller Robert E | Officer | A-Award | A | Stock Option (Right to Buy) | 26,756 | 2.97 | 79.5K | 117,330 | — | ↗ |
| 2013-09-19 | MCLAUGHLIN JOHN | Director | A-Award | A | Stock Option (Right to Buy) | 5,351 | 2.97 | 15.9K | 20,681 | — | ↗ |
| 2013-09-19 | Harish Sameer | Officer | A-Award | A | Stock Option (Right to Buy) | 5,351 | 2.97 | 15.9K | 5,351 | — | ↗ |
| 2013-09-19 | French Gregory M | Director | A-Award | A | Stock Option (Right to Buy) | 8,027 | 2.97 | 23.8K | 90,064 | — | ↗ |
| 2013-09-19 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 8,027 | 2.97 | 23.8K | 68,713 | — | ↗ |
| 2013-09-06 | French Gregory M | Director | A-Award | A | Stock Option (Right to Buy) | 14,035 | 2.75 | 38.6K | 82,037 | — | ↗ |
| 2013-09-06 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 14,035 | 2.75 | 38.6K | 60,686 | — | ↗ |
| 2013-08-16 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock | 5,100 | 2.35 | 12.0K | 14,600 | — | ↗ |
| 2013-03-01 | MCLAUGHLIN JOHN | Director | — | D | Stock Option (Right to Buy) | 50,000 | 0.60 | 30.0K | 0 | — | ↗ |
| 2013-02-01 | Harish Sameer | Officer | — | D | No securities beneficially owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-12-10 | Alimi Hojabr | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 0.64 | 1.9K | 1,028,550 | — | ↗ |
| 2012-12-07 | Alimi Hojabr | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.65 | 1.3K | 1,028,750 | — | ↗ |
| 2012-12-06 | Alimi Hojabr | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 0.64 | 2.5K | 1,020,250 | — | ↗ |
| 2012-11-09 | Schutz James J | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 0.78 | 780.00 | 66,500 | — | ↗ |
| 2012-10-01 | French Gregory M | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.90 | 13.5K | 527,555 | — | ↗ |
| 2012-10-01 | Conley Richard K | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.90 | 13.5K | 545,678 | — | ↗ |
| 2012-10-01 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.90 | 13.5K | 343,649 | — | ↗ |
| 2012-10-01 | Alton Gregg H | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.90 | 13.5K | 305,405 | — | ↗ |
| 2012-08-24 | Schutz James J | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.93 | 139.5K | 1,147,000 | — | ↗ |
| 2012-08-24 | Miller Robert E | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.93 | 139.5K | 852,064 | — | ↗ |
| 2012-08-24 | Birnbaum Jay E | Director | A-Award | A | Stock Option (Right to Buy) | 23,649 | 0.93 | 22.0K | 328,649 | — | ↗ |
| 2012-08-24 | Alton Gregg H | Director | A-Award | A | Stock Option (Right to Buy) | 30,405 | 0.93 | 28.3K | 290,405 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-246.1K
Shares Outstanding
1.73M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Amy Trombly Chief Executive Officer | 325.0K | 162.5K | 37.7K | — | — | 71.8K | 597.1K | 6.32% | ↗ |
| 2 | 2025 | Bruce Thornton Executive Vice President and Chief Operating Officer | 260.8K | 164.0K | 37.7K | — | — | 69.9K | 532.4K | 7.09% | ↗ |
| 3 | 2025 | Jerry Dvonch Chief Financial Officer | 240.0K | 17.8K | 37.7K | — | — | 62.0K | 357.5K | 10.55% | ↗ |
| 4 | 2024 | Amy Trombly Chief Executive Officer | 325.0K | 162.5K | 109.1K | 8.7K | — | 121.3K | 726.5K | 16.20% | ↗ |
| 5 | 2024 | Bruce Thornton Executive Vice President and Chief Operating Officer | 255.4K | 150.0K | 109.1K | 8.7K | — | 135.4K | 658.6K | 17.88% | ↗ |
| 6 | 2024 | Jerry Dvonch Chief Financial Officer | 60.0K | — | 30.0K | 8.7K | — | 208.8K | 307.5K | 12.58% | ↗ |
| 7 | 2023 | Amy Trombly Chief Executive Officer | 318.8K | 162.5K | — | 35.8K | — | 42.9K | 559.9K | 6.38% | ↗ |
| 8 | 2023 | Bruce Thornton Chief Operating Officer | 245.2K | 150.0K | — | 35.8K | — | 53.7K | 484.7K | 7.38% | ↗ |
| 9 | 2023 | Bruce Thornton Executive Vice President and Chief Operating Officer | 245.2K | 150.0K | — | 35.8K | — | 53.7K | 484.7K | 7.38% | ↗ |
| 10 | 2023 | Jerry Dvonch Interim Chief Financial Officer | 142.0K | — | — | — | — | 139.1K | 281.2K | 0.00% | ↗ |
| 11 | 2023 | Jerry Dvonch Chief Financial Officer | 142.0K | — | — | — | — | 139.1K | 281.2K | 0.00% | ↗ |
| 12 | 2023 | Chad White Former Chief Financial Officer | 103.5K | — | — | 18.0K | — | 10.4K | 131.9K | 13.66% | ↗ |
| 13 | 2022 | Amy Trombly Chief Executive Officer | 318.0K | 150.0K | — | 121.0K | — | 54.0K | 643.0K | 18.82% | ↗ |
| 14 | 2022 | Bruce Thornton Chief Operating Officer | 250.0K | 125.0K | — | 121.0K | — | 58.0K | 554.0K | 21.84% | ↗ |
| 15 | 2022 | Jerry Dvonch Interim Chief Financial Officer | 200.0K | 58.0K | — | 121.0K | — | 48.0K | 427.0K | 28.34% | ↗ |
| 16 | 2022 | Jerry Dvonch Chief Financial Officer | 200.0K | 58.0K | — | 121.0K | — | 48.0K | 427.0K | 28.34% | ↗ |
| 17 | 2021 | Amy Trombly Chief Executive Officer | 300.0K | 75.0K | — | 152.0K | — | 53.0K | 580.0K | 26.21% | ↗ |
| 18 | 2021 | Bruce Thornton Chief Operating Officer | 253.0K | 50.0K | — | 152.0K | — | 62.0K | 517.0K | 29.40% | ↗ |
| 19 | 2021 | Jerry Dvonch Chief Financial Officer | 111.0K | — | — | 152.0K | — | 24.0K | 287.0K | 52.96% | ↗ |
| 20 | 2020 | Bubba Sandford Former Chief Executive Officer | 192.0K | 168.0K | — | — | — | 11.6K | 371.6K | 0.00% | ↗ |
| 21 | 2020 | Bruce Thornton Chief Operating Officer | 250.0K | 10.0K | — | 48.0K | — | 58.0K | 366.0K | 13.11% | ↗ |
| 22 | 2020 | John Dal Poggetto Former Chief Financial Officer | 204.2K | — | — | 46.2K | — | 33.8K | 284.2K | 16.27% | ↗ |
| 23 | 2020 | Amy Trombly Chief Executive Officer | 153.0K | — | — | 59.0K | — | 17.0K | 229.0K | 25.76% | ↗ |
| 24 | 2019 | Jim Schutz Former Chief Executive Officer | 176.0K | 796.00 | — | 132.8K | — | 330.9K | 640.5K | 20.74% | ↗ |
| 25 | 2019 | Bubba Sandford CEO, Interim CFO | 106.3K | 42.0K | — | 276.3K | — | 6.1K | 430.8K | 64.14% | ↗ |
| 26 | 2019 | Bubba Sandford Former Chief Executive Officer | 106.0K | 42.0K | — | 276.3K | — | 6.1K | 430.4K | 64.19% | ↗ |
| 27 | 2019 | Bruce Thornton EVP of Int’l Operations and Sales | 250.0K | 1.6K | — | — | — | 58.9K | 310.5K | 0.00% | ↗ |
| 28 | 2019 | Bruce Thornton Chief Operating Officer | 250.0K | 1.6K | — | — | — | 58.9K | 310.5K | 0.00% | ↗ |
| 29 | 2019 | Robert Northey EVP of Research & Development | 204.0K | 1.1K | — | — | — | 46.7K | 251.8K | 0.00% | ↗ |
| 30 | 2018 | Jim Schutz Former Chief Executive Officer | 250.0K | 40.0K | 116.8K | 184.9K | — | 97.4K | 689.1K | 43.77% | ↗ |
| 31 | 2018 | Jim Schutz Chief Executive Officer | 250.0K | 40.0K | 116.7K | 184.9K | — | 97.4K | 689.0K | 43.77% | ↗ |
| 32 | 2018 | Robert Miller Chief Financial Officer | 250.0K | — | 28.6K | 184.9K | — | 54.9K | 518.4K | 41.19% | ↗ |
| 33 | 2018 | Jeffrey Day President of IntraDerm Pharmaceuticals | 232.0K | 51.8K | — | 104.8K | — | 68.1K | 456.6K | 22.94% | ↗ |
| 34 | 2017 | Robert Miller Chief Financial and Operating Officer | 250.0K | — | 103.6K | 207.2K | — | 86.2K | 647.1K | 48.04% | ↗ |
| 35 | 2017 | Robert Miller Chief Financial Officer | 250.0K | — | 75.0K | 207.2K | — | 86.2K | 618.4K | 45.64% | ↗ |
| 36 | 2017 | Jim Schutz Chief Executive Officer | 250.0K | 80.0K | 17.0K | 207.2K | — | 63.7K | 618.0K | 36.29% | ↗ |
| 37 | 2017 | Bruce Thornton EVP of Int’l Operations & Sales | 250.0K | 50.0K | 45.9K | — | — | 70.8K | 416.7K | 11.02% | ↗ |
| 38 | 2017 | Robert Northey EVP of Research and Development | 209.0K | 40.0K | 46.1K | — | — | 59.5K | 354.6K | 13.01% | ↗ |
| 39 | 2016 | Bruce Thornton Executive Vice President of International Operations and Sales | 250.0K | — | — | 40.9K | — | 53.6K | 344.5K | 11.86% | ↗ |
| 40 | 2016 | Bruce Thornton EVP of Int’l Operations & Sales | 250.0K | — | — | 40.9K | — | 53.6K | 344.5K | 11.86% | ↗ |
| 41 | 2016 | Robert Miller Secretary, Chief Financial Officer and Chief Operating Officer | 250.0K | — | — | 30.4K | — | 45.3K | 325.7K | 9.33% | ↗ |
| 42 | 2016 | Robert Miller Chief Financial and Operating Officer | 250.0K | — | — | 30.4K | — | 45.3K | 325.7K | 9.33% | ↗ |
| 43 | 2016 | Jim Schutz Chief Executive Officer | 250.0K | — | — | — | — | 50.6K | 300.6K | 0.00% | ↗ |
| 44 | 2016 | Robert Northey Executive Vice President of Research and Development | 194.0K | 20.0K | — | 38.0K | — | 44.9K | 296.9K | 12.80% | ↗ |
| 45 | 2016 | Robert Northey EVP of Research and Development | 194.0K | — | — | 38.0K | — | 44.9K | 276.9K | 13.72% | ↗ |
| 46 | 2015 | Bruce Thornton Executive Vice President of International Operations and Sales | 250.0K | 20.0K | — | — | — | 55.9K | 325.9K | 0.00% | ↗ |
| 47 | 2015 | Robert Miller Secretary and Chief Financial Officer | 250.0K | — | — | — | — | 6.00 | 321.1K | 0.00% | ↗ |
| 48 | 2015 | Robert Miller Secretary, Chief Financial Officer and Chief Operating Officer | 250.0K | — | — | — | — | 71.1K | 321.1K | 0.00% | ↗ |
| 49 | 2015 | Jim Schutz Chief Executive Officer | 250.0K | — | — | — | — | 46.2K | 296.2K | 0.00% | ↗ |
| 50 | 2015 | Jim Schutz President, Chief Executive Officer and Director | 250.0K | — | — | — | — | 4.00 | 296.2K | 0.00% | ↗ |
| 51 | 2015 | Robert Northey Executive Vice President of Research and Development | 185.0K | 30.0K | — | — | — | 40.8K | 255.8K | 0.00% | ↗ |
| 52 | 2014 | Robert Miller Secretary and Chief Financial Officer | 250.0K | — | — | 423.7K | — | 7.00 | 740.4K | 57.22% | ↗ |
| 53 | 2014 | Bruce Thornton Executive Vice President of International Operations and Sales | 250.0K | — | — | 344.3K | — | 10.00 | 641.9K | 53.64% | ↗ |
| 54 | 2014 | Hoji Alimi Chief Executive Officer of Ruthigen | 12.00 | 13.00 | — | — | — | 14.00 | 596.4K | 0.00% | ↗ |
| 55 | 2014 | Robert Northey Executive Vice President of Research and Development | 185.0K | — | — | 323.7K | — | 13.00 | 545.5K | 59.34% | ↗ |
| 56 | 2014 | Jim Schutz President, Chief Executive Officer and Director | 3.00 | — | — | 180.4K | — | 5.00 | 486.6K | 37.07% | ↗ |
| 57 | 2013 | Hojabr Alimi Chairman of the Board; President and Chief Executive Officer of Ruthigen; Former Chief Executive Officer of Oculus | 375.0K | 402.0K | — | — | — | 95.0K | 872.0K | 0.00% | ↗ |
| 58 | 2013 | Hoji Alimi Chief Executive Officer of Ruthigen | 15.00 | 16.00 | — | — | — | 17.00 | 872.0K | 0.00% | ↗ |
| 59 | 2013 | Jim Schutz President, Chief Executive Officer and Director | 300.0K | — | — | 101.5K | — | 5.00 | 417.4K | 24.32% | ↗ |
| 60 | 2013 | Jim Schutz Chief Executive Officer and Director (Principal Executive Officer) | 300.0K | — | — | 101.5K | — | 15.9K | 417.4K | 24.32% | ↗ |
| 61 | 2013 | Robert Miller Secretary and Chief Financial Officer | 250.0K | — | — | 101.5K | — | 7.00 | 363.8K | 27.90% | ↗ |
| 62 | 2013 | Robert Miller Chief Financial Officer (Principal Financial and Accounting Officer) | 250.0K | — | — | 101.5K | — | 12.3K | 363.8K | 27.90% | ↗ |
| 63 | 2013 | Bruce Thornton Executive Vice President of International Operations and Sales | 250.0K | 9.00 | — | — | — | 10.00 | 321.9K | 0.00% | ↗ |
| 64 | 2013 | Sameer Harish Chief Financial Officer of Ruthigen | 35.5K | — | — | — | — | — | 35.5K | 0.00% | ↗ |
| 65 | 2012 | Hojabr Alimi Chief Executive Officer, President and Chairman (Principal Executive Officer) | 375.0K | 410.0K | — | — | — | 61.0K | 846.0K | 0.00% | ↗ |
| 66 | 2012 | Hojabr Alimi Chairman of the Board; President and Chief Executive Officer of Ruthigen; Former Chief Executive Officer of Oculus | 375.0K | 410.0K | — | — | — | 61.0K | 846.0K | 0.00% | ↗ |
| 67 | 2012 | Jim Schutz Chief Executive Officer and Director (Principal Executive Officer) | 300.0K | — | — | 224.0K | — | 16.1K | 540.1K | 41.47% | ↗ |
| 68 | 2012 | Jim Schutz Chief Operating Officer, General Counsel, and Director | 300.0K | — | — | 224.0K | — | 16.1K | 540.1K | 41.47% | ↗ |
| 69 | 2012 | Robert Miller Chief Financial Officer (Principal Financial and Accounting Officer) | 250.0K | — | — | 253.6K | — | 11.4K | 515.0K | 49.24% | ↗ |
| 70 | 2012 | Bruce Thornton Executive Vice President of International Operations and Sales | 250.0K | — | — | — | — | 21.9K | 271.9K | 0.00% | ↗ |
| 71 | 2011 | Hojabr Alimi Chief Executive Officer, President and Chairman (Principal Executive Officer) | 375.0K | 432.0K | — | — | — | 40.5K | 847.5K | 0.00% | ↗ |
| 72 | 2011 | Jim Schutz Chief Operating Officer, General Counsel, and Director | 300.0K | — | — | 246.5K | — | 16.8K | 563.3K | 43.76% | ↗ |
| 73 | 2011 | Robert Miller Chief Financial Officer (Principal Financial and Accounting Officer) | 250.0K | — | — | 213.3K | — | 9.9K | 473.2K | 45.07% | ↗ |
| 74 | 2010 | Hojabr Alimi Chief Executive Officer, President and Chairman (Principal Executive Officer) | 376.4K | — | — | 215.4K | — | 15.0K | 606.8K | 35.49% | ↗ |
| 75 | 2010 | Jim Schutz Chief Operating Officer, General Counsel, and Director | 257.5K | 23.0K | — | 261.4K | — | 14.1K | 556.0K | 47.01% | ↗ |
| 76 | 2010 | Robert Miller Chief Financial Officer (Principal Financial and Accounting Officer) | 251.0K | — | — | 269.2K | — | 9.9K | 530.1K | 50.78% | ↗ |
| 77 | 2009 | Michael Wokasch Former Chief Operating Officer | 147.6K | — | — | 1.26M | — | 293.5K | 1.70M | 74.03% | ↗ |
| 78 | 2009 | Jim Schutz Vice President, General Counsel, Corporate Secretary and Director | 249.9K | — | — | 161.2K | — | 15.3K | 426.4K | 37.81% | ↗ |
| 79 | 2009 | Hojabr Alimi Chief Executive Officer Principal Executive Officer and Chairman | 374.6K | — | — | 4.3K | — | 11.1K | 390.1K | 1.11% | ↗ |
| 80 | 2009 | Bruce Thornton Executive Vice President | 237.1K | — | — | 63.4K | 45.0K | 16.3K | 361.8K | 17.53% | ↗ |
| 81 | 2009 | Robert Miller Chief Financial Officer | 248.3K | — | — | 2.8K | — | 5.2K | 256.3K | 1.07% | ↗ |
| 82 | 2008 | Michael Wokasch Former Chief Operating Officer | 200.0K | — | — | 284.1K | 100.0K | 13.4K | 597.5K | 47.54% | ↗ |
| 83 | 2008 | Hojabr Alimi Chief Executive Officer Principal Executive Officer and Chairman | 275.0K | — | — | — | 275.0K | 12.2K | 562.2K | 0.00% | ↗ |
| 84 | 2008 | Jim Schutz Vice President, General Counsel, Corporate Secretary and Director | 225.0K | — | — | 139.3K | 112.5K | 13.4K | 490.2K | 28.41% | ↗ |
| 85 | 2008 | Bruce Thornton Executive Vice President | 180.0K | — | — | 49.4K | 90.0K | 12.8K | 332.2K | 14.88% | ↗ |
| 86 | 2008 | Robert Miller Chief Financial Officer | 185.0K | — | — | — | 92.5K | 4.5K | 282.0K | 0.00% | ↗ |
| 87 | 2007 | Robert Miller Chief Financial Officer | 185.0K | — | — | 351.5K | — | — | 536.5K | 65.52% | ↗ |
| 88 | 2007 | Hojabr Alimi | 275.0K | 154.1K | — | — | — | — | 429.1K | 0.00% | ↗ |
| 89 | 2007 | Hojabr Alimi Chief Executive Officer and Chairman | 275.0K | 154.1K | — | — | — | — | 429.1K | 0.00% | ↗ |
| 90 | 2007 | Michael Wokasch Chief Operating Officer | 162.3K | 125.0K | — | 137.6K | — | — | 424.9K | 32.38% | ↗ |
| 91 | 2007 | James Schutz Vice President Corporate Development, Secretary and General Counsel | 190.0K | 60.0K | — | 72.4K | — | — | 322.4K | 22.47% | ↗ |
| 92 | 2007 | Bruce Thornton Vice President International Operations and Sales | 180.0K | 27.5K | — | 27.9K | — | 12.2K | 247.7K | 11.28% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Amy Trombly | Chief Executive Officer, President & Director | 559.3K | female |
| John Dal Poggetto | Controller | 433.4K | male |
| Jerome Dvonch | Chief Financial Officer | 319.8K | male |
| Arturo Angel | Senior Vice President of Regulatory, Quality & Product Development | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SNOA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
